Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Blaug Suzanne, Director. Officer active across 1 company, notably FIBROGEN INC. Cumulatively, 4 filings have been recorded. History available since 26 May 2021. The latest transaction was disclosed on 7 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Suzanne Blaug serves as a Director at FibroGen Inc. As a board member, she contributes to overseeing the company's operations and shaping its strategy. Suzanne brings valuable expertise in the biopharmaceutical sector, helping FibroGen innovate and grow. Her commitment to corporate governance is essential for ensuring transparency and accountability.